Anna Berg Åsberg is Vice President of R&D IT, responsible for strategy, build and run for IT in both Oncology and BioPharmaceuticals R&D. Her global team delivers transactional core IT systems as well as transformational data and insight technologies, including engineering, platform and tools for artificial intelligence and digital health capabilities.
Anna holds a Master of Science degree from KTH, Royal Institute of Stockholm. Prior to joining AstraZeneca in 2004, Anna studied and worked in numerous European countries, including Germany, Spain, Switzerland and France. She developed a passion for applying IT to diverse organizations and challenges, and launched an IT consultancy company in Hamburg, Germany.
Her AstraZeneca career began in Södertälje working with Finance and Enabling Units, followed by a move to the US to provide IT for the U.S. Commercial unit. Anna moved back to Södertälje in 2014 as VP for Operations IT, where she established and started the journey to make AstraZeneca factories ‘smart’ with digital technologies. She assumed her current role in 2019.